Ghisallo Capital Management LLC Vaccitech PLC Transaction History

Ghisallo Capital Management LLC

  • $1.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$8.98 - $15.55 $185,212 - $320,718
-20,625 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$14.0 - $16.5 $148,750 - $175,312
10,625 Added 106.25%
20,625 $325,000
Q2 2021

Aug 16, 2021
BUY
$13.03 - $17.0 $130,300 - $170,000
10,000 New
10,000 $168,000

Others Institutions Holding VACC

# of Institutions
20
Shares Held
14.9M
Call Options Held
0
Put Options Held
0
View Full List

About Vaccitech plc

VACC Quotes by TradingView
  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Ghisallo Capital Management LLC Portfolio

Follow Ghisallo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghisallo Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email